CGT Catapult collaborates with companies, academic researchers and healthcare services to advance cell and gene therapies. The organisation provides access to specialist expertise covering all aspects of advanced therapies, unique infrastructure and capabilities to help companies overcome barriers to commercialisation, scale operations and grow. It works across three areas: maintaining dialogue with the research base to move promising science toward the clinic, finding and backing high potential companies with expert support and investment, and creating the environment for those companies to thrive through work on manufacturing, regulation and NHS adoption. In the last financial year, CGT Catapult worked with 81 companies on advanced therapy innovation, 70% of which are UK-based small and medium-sized enterprises.
This is the employer describing itself, in its own words. We do not rate or review employers, and nothing here is our opinion of one.